Armetheon

18 articles about Armetheon

• Ekso Bionics Appoints Jack Glenn as Chief Financial Officer

  8/13/2018

  Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that John (Jack) Glenn has been appointed to the position of Chief Financial Officer.

• Espero Pharma And Armetheon To Merge And Create A Premier Cardiovascular Focused Biopharmaceutical Company

  3/31/2017

• Armetheon Announces EMA's Support For 1000 Patient Single Phase lll Study Prior To MAA Filing For Its Novel Oral Anticoagulant Tecarfarin

  2/14/2017

• Armetheon Announces Issuance Of A New U.S. Patent For Its Phase 2 Clinical Stage Novel Oral Anti-Arrhythmic Budiodarone

  2/13/2017

• Armetheon Reaches Agreement With FDA To Conduct A 1000 Patient Single Phase 3 Study Prior To NDA Filing For Its Novel Oral Anticoagulant Tecarfarin

  2/9/2017

• Armetheon Announces Positive Results Of Pharmacokinetics Study Of Tecarfarin Versus Warfarin

  8/25/2016

• Armetheon Announces Positive Tecarfarin Clinical Data To Be Presented At The European Society of Cardiology Congress

  8/23/2016

• Armetheon Completes Acquisition Of Budiodarone And Plans Development For The Treatment Of Ventricular Tachycardia In Patients With Implantable Cardioverter Defibrillators

  5/26/2016

• Armetheon To Participate In Two Events During Week Of J.P. Morgan Healthcare Conference

  1/5/2016

• Armetheon To Present At The 14th Annua BIO Investor Forum

  10/14/2015

• Armetheon To Participate In The Hume Brophy 7th Annual Healthcare Conference

  10/8/2015

• Armetheon And Lee's Pharmaceutical Enter Into Agreement To Develop And Commercialize Tecarfarin In Greater China And Thailand

  9/22/2015

• Armetheon To Present At The 22nd Annual Newsmakers In The Biotech Industry Conference

  9/8/2015

• Armetheon Expands Leadership Team, Names Detlef Albrecht, M.D., As Chief Medical Officer

  8/18/2015

• Armetheon Names Dr. Sanjay Kakkar As Chief Executive Officer

  6/3/2015

• Armetheon Announces Appointment Of Andrew C. Lam As Vice President Of Product Development

  5/8/2015

• Armetheon Closes $24 Million Series B Financing

  2/5/2015

• Menlo Park Startup Armetheon Snags $7 Million Series A Financing

  8/28/2014